Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Rex

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Microbiology|January 1, 1997
Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin BM Lozano-Chiu, P W Nelson, M Lancaster, et al.
Journal of Clinical Microbiology|August 17, 1999
Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibilityM Lozano-Chiu, S Arikan, V L Paetznick, et al.
Journal of Clinical Microbiology|July 1, 1996
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolatesM A Pfaller, S A Messer, A Bolmström, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 18, 2003
Voriconazole salvage treatment of invasive candidiasisL Ostrosky-Zeichner, A M L Oude Lashof, B J Kullberg, et al.
Clinical Pharmacology and Therapeutics|May 15, 2014
The challenge of antimicrobial resistance: new regulatory tools to support product developmentJ F Tomayko, J H Rex, D M Tenero, et al.
Clinical Microbiology Reviews|October 1, 1993
Antifungal susceptibility testingJ H Rex, M A Pfaller, M G Rinaldi, et al.
Journal of Clinical Microbiology|June 6, 2007
Does one voriconazole breakpoint suit all Candida species?Maiken Cavling Arendrup, David W Denning, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatographyJ H Rex, L H Hanson, M A Amantea, et al.
The Journal of Infectious Diseases|August 1, 1990
Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphaeJ H Rex, J E Bennett, J I Gallin, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1995
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study GroupJ H Rex, M A Pfaller, A L Barry, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Microbiology|January 1, 1997
Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin BM Lozano-Chiu, P W Nelson, M Lancaster, et al.
Journal of Clinical Microbiology|August 17, 1999
Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibilityM Lozano-Chiu, S Arikan, V L Paetznick, et al.
Journal of Clinical Microbiology|July 1, 1996
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolatesM A Pfaller, S A Messer, A Bolmström, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 18, 2003
Voriconazole salvage treatment of invasive candidiasisL Ostrosky-Zeichner, A M L Oude Lashof, B J Kullberg, et al.
Clinical Pharmacology and Therapeutics|May 15, 2014
The challenge of antimicrobial resistance: new regulatory tools to support product developmentJ F Tomayko, J H Rex, D M Tenero, et al.
Clinical Microbiology Reviews|October 1, 1993
Antifungal susceptibility testingJ H Rex, M A Pfaller, M G Rinaldi, et al.
Journal of Clinical Microbiology|June 6, 2007
Does one voriconazole breakpoint suit all Candida species?Maiken Cavling Arendrup, David W Denning, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatographyJ H Rex, L H Hanson, M A Amantea, et al.
The Journal of Infectious Diseases|August 1, 1990
Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphaeJ H Rex, J E Bennett, J I Gallin, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1995
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study GroupJ H Rex, M A Pfaller, A L Barry, et al.
Pageof 11